Raymond James Financial Services Advisors’s Cytosorbents Corp CTSO Stock Holding History

Raymond James Financial Services Advisors’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$90.9K	Hold	60,591	–	–	﹤0.01%	3300
2024 Q2	$42.6K	Hold	60,591	–	–	﹤0.01%	3310
2024 Q1	$57.6K	Hold	60,591	–	–	﹤0.01%	3283
2023 Q4	$67.3K	Sell	60,591 -1,340	-2%	-$1.99K	﹤0.01%	3168
2023 Q3	$116K	Hold	61,931	–	–	﹤0.01%	3042
2023 Q2	$222K	Buy	61,931 +438	+0.7%	+$1.39K	﹤0.01%	2861
2023 Q1	$207K	Sell	61,493 -997	-2%	-$2.99K	﹤0.01%	2885
2022 Q4	$96.9K	Buy	62,490 +1,151	+2%	+$1.71K	﹤0.01%	3015
2022 Q3	$83K	Buy	61,339 +362	+0.6%	+$707	﹤0.01%	3023
2022 Q2	$134K	Buy	60,977 +3,293	+6%	+$7.56K	﹤0.01%	2964
2022 Q1	$184K	Buy	57,684 +10,141	+21%	+$36.3K	﹤0.01%	2990
2021 Q4	$199K	Buy	+47,543	New	+$267K	﹤0.01%	2983

Other funds holding CTSO

Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Raymond James Financial Services Advisors's CTSO Position: Q3 2024 in Review

Raymond James Financial Services Advisors held its Cytosorbents Corp (CTSO) position steady in Q3 2024 at 60,591 shares worth $90.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3300.

Raymond James Financial Services Advisors first reported a position in CTSO in Q4 2021 and has held it in 12 quarters since. The position peaked at $222K in Q2 2023. 53 funds tracked by Wall St. Rank hold CTSO as of Q3 2024.

Raymond James Financial Services Advisors held 60,591 shares of Cytosorbents Corp worth $90.9K as of Q3 2024.
Raymond James Financial Services Advisors left its Cytosorbents Corp share count unchanged in Q3 2024.
Cytosorbents Corp made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #3300 holding.
Raymond James Financial Services Advisors first reported a position in Cytosorbents Corp in Q4 2021 and has held it in 12 quarters since.
Raymond James Financial Services Advisors's Cytosorbents Corp position peaked at $222K in Q2 2023.
53 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.